BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32896064)

  • 1. PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study.
    Bessi V; Giacomucci G; Mazzeo S; Bagnoli S; Padiglioni S; Balestrini J; Tomaiuolo G; Piaceri I; Carraro M; Bracco L; Sorbi S; Nacmias B
    Eur J Neurol; 2021 Jan; 28(1):56-65. PubMed ID: 32896064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Effect of
    Mazzeo S; Bessi V; Bagnoli S; Giacomucci G; Balestrini J; Padiglioni S; Tomaiuolo G; Ingannato A; Ferrari C; Bracco L; Sorbi S; Nacmias B
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of
    Bessi V; Balestrini J; Bagnoli S; Mazzeo S; Giacomucci G; Padiglioni S; Piaceri I; Carraro M; Ferrari C; Bracco L; Sorbi S; Nacmias B
    J Pers Med; 2020 May; 10(2):. PubMed ID: 32485802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
    Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study.
    Mazzeo S; Padiglioni S; Bagnoli S; Bracco L; Nacmias B; Sorbi S; Bessi V
    J Neurol; 2019 Feb; 266(2):487-497. PubMed ID: 30604054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    Caillaud M; Maltezos S; Hudon C; Mellah S; ; Belleville S
    J Alzheimers Dis; 2023; 94(3):1047-1056. PubMed ID: 37355896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment.
    Mazzeo S; Bessi V; Padiglioni S; Bagnoli S; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2019 Aug; 40(8):1559-1566. PubMed ID: 30953258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Reserve, Brain Reserve, APOEɛ4, and Cognition in Individuals with Subjective Cognitive Decline in the SILCODE Study.
    Yang K; Chen G; Sheng C; Xie Y; Li Y; Hu X; Sun Y; Han Y
    J Alzheimers Dis; 2020; 76(1):249-260. PubMed ID: 32444543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of Brain Reserve on Cognition in Individuals with Subjective Cognitive Decline from the SILCODE Study.
    Chen G; Liu C; Yang K; Li Y; Sheng C; Xie Y; Hu X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 75(4):1203-1210. PubMed ID: 32417777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in cognitive reserve: implication for subjective cognitive decline in women.
    Giacomucci G; Mazzeo S; Padiglioni S; Bagnoli S; Belloni L; Ferrari C; Bracco L; Nacmias B; Sorbi S; Bessi V
    Neurol Sci; 2022 Apr; 43(4):2499-2508. PubMed ID: 34625855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blink Rate Study in Patients with Alzheimer's Disease, Mild Cognitive Impairment and Subjective Cognitive Decline.
    D'Antonio F; Bartolo MI; Ferrazzano G; Monti MS; Imbriano L; Trebbastoni A; Berardelli A; Conte A
    Curr Alzheimer Res; 2021; 18(14):1104-1110. PubMed ID: 34961444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clock T3111C and Per2 C111G SNPs do not influence circadian rhythmicity in healthy Italian population.
    Choub A; Mancuso M; Coppedè F; LoGerfo A; Orsucci D; Petrozzi L; DiCoscio E; Maestri M; Rocchi A; Bonanni E; Siciliano G; Murri L
    Neurol Sci; 2011 Feb; 32(1):89-93. PubMed ID: 20886252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    Wang Q; Chen B; Zhong X; Zhou H; Zhang M; Mai N; Wu Z; Huang X; Haehner A; Chen X; Auber LA; Peng Q; Hummel T; Ning Y
    J Alzheimers Dis; 2021; 79(2):585-595. PubMed ID: 33361601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network approach to subjective cognitive decline: Exploring multivariate relationships in neuropsychological test performance across Alzheimer's disease risk states.
    Grunden N; Phillips NA; ;
    Cortex; 2024 Apr; 173():313-332. PubMed ID: 38458017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.